Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $414.5 million.

  • Agilon Health's Shares Outstanding (Diluted Average) rose 69.83% to $414.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.5 million, marking a year-over-year increase of 69.83%. This contributed to the annual value of $411.0 million for FY2024, which is 50.11% up from last year.
  • Agilon Health's Shares Outstanding (Diluted Average) amounted to $414.5 million in Q3 2025, which was up 69.83% from $413.8 million recorded in Q2 2025.
  • Agilon Health's 5-year Shares Outstanding (Diluted Average) high stood at $426.6 million for Q1 2023, and its period low was $325.7 million during Q1 2021.
  • For the 5-year period, Agilon Health's Shares Outstanding (Diluted Average) averaged around $403.2 million, with its median value being $411.1 million (2022).
  • As far as peak fluctuations go, Agilon Health's Shares Outstanding (Diluted Average) surged by 3021.75% in 2022, and later crashed by 413.7% in 2024.
  • Quarter analysis of 5 years shows Agilon Health's Shares Outstanding (Diluted Average) stood at $372.9 million in 2021, then increased by 9.44% to $408.2 million in 2022, then increased by 0.19% to $408.9 million in 2023, then grew by 0.5% to $411.0 million in 2024, then rose by 0.85% to $414.5 million in 2025.
  • Its last three reported values are $414.5 million in Q3 2025, $413.8 million for Q2 2025, and $412.9 million during Q1 2025.